ClinVar Miner

Submissions for variant NM_015102.5(NPHP4):c.133C>T (p.Gln45Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000681812 SCV000890172 pathogenic not provided 2018-07-30 criteria provided, single submitter clinical testing The Q45X variant in the NPHP4 gene has been reported previously in the heterozygous state in an individual with nephronophthisis-related ciliopathy who had end-stage renal disease and no extra-renal manifestations (Halbritter et al., 2013). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Q45X variant is observed in 9/126,618 alleles (0.0071%) from individuals of non-Finnish European background, and 9/277,008 global alleles (0.0032%) in large population cohorts (Lek et al., 2016). We interpret Q45X as a pathogenic variant.
Gharavi Laboratory,Columbia University RCV000681812 SCV000809283 pathogenic not provided 2018-09-16 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.